Manuel Angel F. M.
- Country
- Spain
- Department
- Psiquiatría
Research Overview
- Phase 2/3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EXV-802 and EXV-801 in Participants with Agitation in Alzheimer’s Disease
- Efficacy and Safety of Psilocybin (COMP360) in Adults with Treatment-Resistant Depression: A Phase III Randomized, Double-Blind, Controlled Trial
- Long-term Safety Evaluation of Iclepertin in Schizophrenia Patients Post-Completion of Phase III Trials
Data & Insights
Has run more than one trial at 134 of 351 partner sites.
Specializations
Psychiatric Therapeutics
The investigator specializes in the treatment of schizophrenia, with particular emphasis on addressing negative symptoms and cognitive impairment associated with this condition.
- Negative Symptom Management
- Cognitive Function Assessment
- Novel Therapeutic Approaches
Their research explores innovative therapeutic interventions in the field of psychiatric disorders.
Neuropsychiatric Research
The investigator focuses on evaluating new therapeutic compounds for psychiatric disorders, particularly those targeting cognitive and behavioral symptoms.
- Therapeutic Efficacy Studies
- Clinical Outcome Assessment
- Treatment Response Evaluation
Their work involves assessing novel treatments for complex psychiatric conditions.
Clinical Neuroscience
The investigator examines the relationship between neurological function and psychiatric symptoms, particularly in schizophrenia spectrum disorders.
- Symptom Assessment
- Treatment Response Monitoring
- Clinical Outcomes Research
Their research encompasses comprehensive evaluation of therapeutic interventions in psychiatric care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.